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Abstract
Short-chain fatty acids, especially butyrate, play beneficial roles in sustaining gastrointestinal health. However, due
to limitations associated with direct consumption of butyrate, there has been interest in using prodrugs of butyrate.
Tributyrin (TB), a triglyceride composed of three butyrate molecules and a glycerol, is a well-studied precursor of
butyrate. We screened a metagenome library consisting of 5760 bacterial artificial chromosome clones, with DNA
inserts originating from mouse microbiomes, and identified two clones that efficiently hydrolyse TB into butyrate.
Nucleotide sequence analysis indicated that inserts in these two clones are derived from unknown microbes.
BLASTp analysis, however, revealed that each insert contains a gene homologous to acetylesterase or esterase
genes, from Clostridium spp. and Bacteroides spp., respectively. Predicted structures of these two proteins both
contain serine-histidine-aspartate catalytic triad, highly conserved in the family of esterases. Escherichia coli host
expressing each of the two candidate genes invariably produced greater amounts of butyrate in the presence of
TB. Importantly, administration of TB together with cloned E. coli cells alleviated inflammatory symptoms in a
mouse model of acute colitis. Based on these results, we established an efficient on-site and real-time butyrate
production system that releases butyrate in a controlled manner inside the intestine.
Keywords: Tributyrin, Butyrate, Esterase, Prodrug, Microbiome, Metagenomic library, Colitis, Inflammatory bowel
disease (IBD), Bacteroidales, Clostridiales
Introduction
Our immanent symbiont, the intestinal microbiome, has
been intensely studied due to its realised impact on
human physiology. Dysbiosis of commensal bacteria and
alteration of commensal-derived metabolites in the gut
trigger greater vulnerability to pathogenic infections,
inappropriate immune response or even systematic
disorders [1]. Among various bacterial metabolites
produced in the gut, short chain fatty acids (SCFAs) are
mainly produced by anaerobic fermentation of indigestible
polysaccharides by commensal anaerobes, and SCFAs
have been highlighted as a key factor for sustaining gut
homeostasis [2]. In particular, butyrate, one of the major
SCFAs in the gastrointestinal tract, serves as a major en-
ergy source for colonocytes and also a signalling molecule
as histone deacetylase inhibitor and a ligand of GPR41 or
GPR43 receptor [3, 4]. Ultimately, butyrate can enhance
the gut barrier function of intestinal epithelial cells, exert
anti-inflammatory effects, and suppress the occurrence of
colorectal cancer [5–7].
Inflammatory bowel disease (IBD), of which major
subtypes are ulcerative colitis (UC) and Crohn’s disease
(CD), is a chronic and relapsing inflammatory condition
in the gastrointestinal tract accompanied by persistent
diarrhoea, abdominal pain, rectal bleeding, and weight
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loss [8]. Though the exact trigger of IBD remains un-
clear, many research indicate that IBD is a result of in-
appropriate immune response in genetically susceptible
individuals [9].
Emerging evidence strongly suggests that dysbiosis of
the gut microbiome and IBD are highly correlated, dem-
onstrated by the compositional differences between the
stool samples of IBD patients and healthy controls [10]. A
significant change of microbial diversity in the IBD stool
samples is decreased abundance of Ruminococcaceae
(Clostridium cluster IV) and Lachnospiraceae (Clostrid-
ium cluster XIVa) [10, 11], which are famous butyrate-
producing bacteria [12], compared to stool samples from
healthy individuals. Depletion of butyrate in IBD patients
might be related to the decreased abundance of butyrate-
producing bacteria [13]. Thus, administering either the
butyrate-producing bacteria or butyrate itself has been
considered as a potential therapeutic agent for the treat-
ment of IBD via its anti-inflammatory effects [14–16].
In spite of the prominent therapeutic potential of bu-
tyrate, its actual usage in the clinical setting has been
met with scepticism due to the short half-life of butyrate.
For instance, when butyrate was intravenously adminis-
tered to a child with leukaemia (500 mg/kg body weight
per day) over a period of several days, limited change in
prognosis was made, on the account of the short half-life
of butyrate of 6 min, and low peak serum levels of butyr-
ate observed [17]. Similarly, a separate study measured
the blood concentrations of butyrate, and showed a
rapid elimination following the intravenous injection of
arginine butyrate [18]. Moreover, clinically utilizing
dietary fibre as major source of butyrate also seems
infeasible. The estimated amount of dietary fibre re-
quired to observe clinical efficacy for an average indi-
vidual is 136 g per 1000 kcal, which is approximately
9.7 times more than that of the recommended intake
of 14 g per 1000 kcal [19].
In order to overcome this issue of butyrate administra-
tion, there has been growing interest in utilizing butyrate
derivatives or prodrugs which are more stable and thus
more of the administered drug reaches the target site.
One of the most prominent prodrugs of butyrate is tri-
butyrin (TB), which is a triglyceride composed of three
butyric acid molecules and a glycerol. Butter is one of
the richest dietary sources of TB, containing up to 3–4%
of its weight [20]. When TB is ingested, for example
through consumption of butter, it gets degraded by hep-
atic lipases releasing 3 butyrate molecules. Thus, dietary
intake of TB is expected to yield similar beneficial results
as direct consumption of butyrate. A pharmacokinetic
study of TB shows that the plasma half-life of butyrate
after TB administration is 40 min, which is longer than
that of direct butyrate administration [20]. Furthermore,
many studies have shown that TB reduces the level of
pro-inflammatory cytokines, induces apoptosis of co-
lonic cancer cells similarly to butyrate [21]. In vivo ex-
periment using a rat model of colon carcinogenesis also
showed that TB exerts anti-cancer effects [22].
We hypothesized that gut commensal microbes may
play a role in TB metabolism and that the resulting me-
tabolites, especially butyrate, may provide health benefits
to host. In this research, we screened a metagenomic
library constructed using the mouse gut commensal
microbiome and identified two novel esterase genes
whose products efficiently breakdown TB into butyrate.
Finally, we tested the anti-inflammatory effects of the
combination of TB and commensal Escherichia coli
clones that express the esterase genes in dextran
sulphate sodium (DSS)–induced colitis mouse model.
Results
Tributyrin (TB) degrading clones exhibited butyrate
producing capability
Since TB is an ester derived from a glycerol and 3 mole-
cules of butyrate, we postulated that enzymes that can ca-
tabolize TB may produce butyrate. Hence, we sought to
establish an efficient screening method for high-throughput
identification of bacterial clones that express such TB-
degrading enzymes. We took advantage of the fact that agar
plates containing dissolved TB (Tributyrin Agar, TBA) ap-
pear turbid, and that upon TB degradation, the agar turns
transparent. Indeed, we observed that bacterial clones pro-
ducing TB-degrading enzymes, such as PAO1 strain of
Pseudomonas aeruginosa, form colonies with halos of a
cleared zone on TBA (data not shown). Using this simple
yet effective screening scheme (Fig. 1a), we screened a
metagenomic library consisting of 5760 bacterial artificial
chromosome (BAC) clones, where each DNA insert was
purified from the gut microbiome of BALB/c mice [23]. An
E. coli DH10B that contains the pIndigoBAC-5 vector with
no insert was used as negative control. Two clones (33E2
and 54E5) exhibited prominent halos around the colony on
TBA following 48 h growth (Fig. 1b). These two TB-
degrading clones were subsequently isolated and evaluated
for butyrate production. Quantitative measurement of bu-
tyrate using HPLC implicated that 33E2 and 54E5 pro-
duced > 8 times and > 3 times more butyrate, respectively,
than the control strain in the presence of 20mM of the
substrate TB (Fig. 1c). This quantitative butyrate measure-
ment is consistent with what was observed on the TB plate
(Fig. 1b). In addition, we also confirmed that overnight cul-
tures of 33E2 and 54E5 produced the characteristic smell
which signalled butyrate production.
Sequence analysis of 33E2 and 54E5 reveals the genes
responsible for TB degradation
In order to better understand the genes related to TB
degradation, the vectors of 33E2 and 54E5 were
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sequenced and analysed. Consequently, the sequence of
33E2, which contains a 10.4 kb insert, was fully assem-
bled as a complete circular contig. In contrast, the
inserted sequence of the 54E5 clone was assembled as
three contigs. Based on the lengths of these three con-
tigs, the insert size of the 54E5 clone is estimated to be
larger than 64.7 kb.
When BLASTn searches were performed using the se-
quences of the 33E2 and 54E5 inserts as query, no sig-
nificant alignment was retrieved, suggesting that the
inserts of these two clones are derived from microbes
with unknown genome sequences (Tables 1 and 2).
However, the 33E2 insert is most similar to a region of
Blautia producta genome with 74.3% identity (Table 1).
Third, fourth and fifth highest-ranking hits of the
BLASTn search were identified as genomic sequences
from Clostridium lentocellum, Herbinix sp. and Cellulo-
silyticum sp. bacteria, respectively, all of which belong to
the Lachnospiraceae family [24, 25]. Contig1 and contig3
of the 54E5 insert share regions of high homology with
genomic regions of Duncaniella sp. (Table 2). No se-
quence with significant homology to contig2 was
detected by BLASTn. Disregarding contig2, most of the
hits in Table 2 are associated with members of the
Muribaculaceae family [26]. These results suggest that
the DNA inserts of 33E2 and 54E5 have originated from
bacteria belonging to Lachnospiraceae and Muribacula-
ceae, respectively. Of note, the predicted origin informa-
tion of the 33E2 and 54E5 DNA fragments are
consistent with the information derived from the
BLASTp search of amino acid sequences as query.
The sequence of the 33E2 insert contains 9 ORFs in-
cluding the first ORF that encodes a putative esterase
(Fig. 2a). Although the species origin of the DNA frag-
ment cannot be ascertained, all of the ORFs within the
33E2 insert encode proteins highly homologous to those
of Lachnospiraceae family, whose members are well-
known producers of short-chain fatty acids [10]. The list
of proteins encoded by 33E2 insert genes is provided in
Supplementary Information (Table S1). The protein
Fig. 1 TB degradation of 33E2 and 54E5 clones. a Schematic diagram of TB esterase screening of BAC clones. b Representative images of a clear
zone formation around TB degrading positive clones, 33E2 and 54E5. E. coli DH10B containing pIndigoBAC-5 (vector-only control) is also shown
as a control. c Measurement of butyrate production by 33E2 and 54E5 in the presence of 20 mM of TB. Three independent experiments were
performed, and values (means ± SEM) are displayed in each bar. **, P < 0.05 compared to Control
Table 1 List of BLASTn search results of inserted DNA sequence of 33E2
Contig Rank* Description Query Cover E value Identity (%) Accession
33E2 1 Blautia producta strain PMF1 chromosome, complete genome 56% 0 74.3 CP035945.1
2 Paenibacillus riograndensis SBR5 genome assembly SBR5(T), chromosome: I 33% 1.00E-80 63.2 LN831776.1
3 Clostridium lentocellum DSM 5427, complete genome 5% 2.00E-34 67.41 CP002582.1
4 Herbinix sp. SD1D genome assembly SD1D, chromosome: I 4% 2.00E-28 67.9 LN879430.1
5 Cellulosilyticum sp. WCF-2 chromosome, complete genome 5% 6.00E-28 66.91 CP034675.1
* Rank of the result is arranged in order of E-value
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encoded by ORF1 (795 bp, 240 aa) is most homologous to
the alpha/beta hydrolase fold domain-containing protein
of Cellulosilyticum lentocellum with 60.46% amino acid
sequence identity. Second-ranked is a protein with the
same description and produced by another species of the
same genus, Cellulosilyticum (Fig. 2a). Other proteins in
the list are acetylesterases, either from the genus of Clos-
tridium or Herbinix (Fig. 2a). These results strongly sug-
gest that TB-degrading capability of the 33E2 clone can be
attributed to the enzymatic activity of this gene product.
The sequence of the 54E5 insert contains 32 ORFs and
90.6% (29 ORFs) of the encoded proteins are highly hom-
ologous to proteins from the Bacteroidales order (Fig. 2b).
The very first gene in contig3 (1194 bp, 397aa) was deter-
mined to encode a protein, whose amino acid sequence is
highly homologous to a Muribaculaceae bacterium esterase
with 86.9% identity. Proteins retrieved from the BLASTp
search using this protein as query similarly include esterases
or alpha/beta hydrolases from species of the Bacteroides
genus (Fig. 2b). Hereafter, we named ORF1 of 33E2 and
ORF1 of the 54E5 contig1 as tbe1 and tbe2, respectively,
with tbe standing for “tributyrin esterase”.
Characterization of Tbe1 and Tbe2
In an effort to shed light on the molecular nature of
Tbe1 and Tbe2, the respective amino acid sequences
were examined using InterPro and SignalP5.0. Analysis of
Tbe1 revealed the lack of a signal peptide in the amino
acid sequence implying that Tbe1 is probably an intracel-
lular protein. In contrast, Tbe2 amino acid sequence in-
cludes a signal peptide sequence, from residue 1 to 19
(Fig. 3a, red underlined), which suggests that Tbe2 may be
an extracellular protein. Furthermore, amino acid se-
quences of Tbe1 and Tbe2 were compared with those of
the known TB esterases of Lactobacillus lactis (LL_Tbe)
and Streptococcus pneumoniae (SP_Est) [27, 28]. All of the
proteins contained an alpha-beta hydrolase conserved do-
main (InterPro entry: IPR029058), which is common to
hydrolytic enzymes (Fig. 3a). In addition, we also detected
the presence of a serine-histidine-aspartate (SHD) catalytic
motif, included within the active sites of most alpha-beta
hydrolase fold super family proteins [29] (Fig. 3a). Further-
more, all SHD motifs found in our analysis contained 3
consensus sequences (LLHG, GLSMGG, and DFL)
(Fig. 3a, highlighted in black).
We then asked whether Tbe1 and Tbe2 proteins are
structurally similar to a known esterase. Structures of
Tbe1 and Tbe2 were simulated based on the 3D struc-
ture of S. pneumoniae EstA [28] from the RSCB Protein
Data Bank (PDB entry: 2UZ0) as template. Tbe1 shares
the overall structural similarity with the template to a
greater extent than Tbe2 does (Fig. 3b). However, the
SHD triad, found in both Tbe1 and Tbe2 conserved
within the catalytic core region, is nicely superimposed
with that of the S. pneumoniae esterase. These results
strongly suggest that Tbe1 and Tbe2 are responsible for
Table 2 List of BLASTn search results of inserted DNA sequence of 54E5
Contig Rank* Description Query Cover E value Identity (%) Accession
54E5
Contig1
1 Duncaniella sp. B8 chromosome, complete genome 9% 0 95.53 CP040121.1
2 Duncaniella sp. C9 chromosome 9% 0 95.53 CP039547.1
3 Muribaculaceae bacterium DSM 108610 strain Oil-RF-744-WCA-WT-10
chromosome, complete genome
9% 5.00E-133 70.62 CP045696.1
4 Muribaculum intestinale strain YL27 chromosome, complete genome 9% 9.00E-143 87.47 CP015402.2
5 Muribaculum intestinale strain YL27 genome 9% 9.00E-143 87.47 CP021421.1
54E5
Contig2
1 Uncultured bacterium clone NOD_dss_A3_G08 16S ribosomal RNA gene,
partial sequence
5% 0 99.93 JQ083840.1
2 Uncultured bacterium clone WT_ctrl_D1_G10 16S ribosomal RNA gene,
partial sequence
5% 0 99.87 JQ084982.1
3 Uncultured bacterium clone NOD_ctrl_C1iii_C05 16S ribosomal RNA gene,
partial sequence
5% 0 99.87 JQ084661.1
4 Uncultured bacterium clone WT_dss_B5_H07 16S ribosomal RNA gene,
partial sequence
5% 0 99.87 JQ084456.1
5 Uncultured bacterium clone WT_dss_B1_C01 16S ribosomal RNA gene,
partial sequence
5% 0 99.87 JQ084160.1
54E5
Contig3
1 Duncaniella sp. B8 chromosome, complete genome 34% 0 94.98 CP040121.1
2 Duncaniella sp. C9 chromosome 34% 0 94.98 CP039547.1
3 Duncaniella dubosii strain H5 chromosome 33% 0 89.59 CP039396.1
4 Uncultured bacterium BAC25G1 genomic sequence 26% 0 95.45 KC595277.1
5 Muribaculum intestinale strain YL27 chromosome, complete genome 34% 0 84.81 CP015402.2
* Rank of the result is arranged in order of E-value
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TB degradation and butyrate biosynthesis in the 33E2
and 54E5 clones.
Relative activity of Tbe1 or Tbe2 with the known TB
esterases
Next, we compared the enzyme activity of Tbe1 and
Tbe2 with previously reported tributyrin esterases [27,
30]. To this end, we further cloned genes encoding the
esterase of Lactococcus lactis (LL_Tbe) and Streptococcus
pneumoniae (SP_Est). In order to evaluate the enzyme
activities under the same condition, all four genes were
cloned into the same location in the pBAD24 plasmid,
which is downstream of the promoter sequence of tbe1.
The bacterial strains were then incubated with 4-
nitrophenyl butyrate (p-NPB), a substrate of the enzyme.
Hydrolysis of p-NPB by the esterase enzyme releases 4-
nitrophenolate, which can be detected by absorbance at
400 nm. Based on Fig. 4, the esterase of S. pneumoniae
was the most potent among the four tested enzymes. Of
note, Tbe2 is more active than Tbe1, and Tbe1 demon-
strated almost identical activity to the L. lactis enzyme.
While using purified enzymes is more preferable for a
precise quantification of the enzyme’s kinetic parame-
ters, these results clearly suggest that Tbe1 and Tbe2,
which we identified in the current study, are either as
equally as or more active than the esterase of L. lactis, a
probiotic strain.
Tbe1 and Tbe2 degrade TB and produce butyrate
Our bioinformatic analyses clearly suggest that Tbe1 and
Tbe2 are the most probable proteins contributing to
conversion of TB into butyrate. In order to conclusively
determine the roles of Tbe1 and Tbe2, we cloned tbe1
and tbe2 genes into another E. coli host and monitored
TB-induced butyrate production. The host strain we
used for Tbe expression is the tEc strain that we isolated
from the mouse intestines [31]. tbe1 gene was amplified
to include ~ 100 bp sequence upstream of the tbe1 ORF
and cloned into pBAD24 plasmid (pBAD24::tbe1). Inclu-
sion of the upstream sequence was intended to enable
transcription of tbe1 using its endogenous promoter.
tbe2 gene was inserted right at the junction of the 54E5
Fig. 2 Open reading frame (ORF) maps and BLASTp results of 33E2 and 54E5 clones. ORF maps of the (a) 33E2 and (b) 54E5 clones. The length
and direction of the arrows indicate the relative size and direction of each ORF. Detailed information of the ORFs is described in supplementary
information. ORFs encoding putative esterases, Tbe1 and Tbe2, are coloured red and orange, respectively, and the top 5 BLASTp hits of the ORFs
are listed in the table arranged by increasing e-value
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plasmid (Fig. 2b), so we were unable to clone tbe2 with
its endogenous promoter. Therefore, tbe2 gene was
cloned in place of the tbe1 ORF in pBAD24::tbe1, and
the resultant plasmid was named pBAD24::tbe2. When
tEc strains harbouring either plasmids were grown in the
presence of 5 mMTB, prominent increases in butyrate
production level were observed (Fig. 5). Butyrate produc-
tion levels in these two cultures were > 16 times higher
than the control culture. The characteristic scent of bu-
tyrate was again noticed in these two cultures.
Of interest, the level of butyrate produced by tbe2
gene was almost identical to that by tbe1 gene. In Fig.
1c, butyrate production by 54E5 was substantially less
than that by 33E2. We speculate that this discrepancy
was caused by the absence of tbe2 gene’s own endogen-
ous promoter in the original 54E5 clone. In 54E5, tbe2
gene expression was probably induced by the upstream
sequence part of the pIndigoBAC-5 plasmid. When tbe2
was transcribed in the presence of the tbe1 promoter in
pBAD24::tbe2, greater butyrate production was achieved.
In vivo on-site butyrate production protects mice against
DSS-induced colitis
Our results so far demonstrate that TB together with
Tbe-expressing E. coli cells can efficiently produce bu-
tyrate, a beneficial microbiome-derived metabolite. To
examine whether or not butyrate produced by this sys-
tem can alleviate intestinal inflammation, we used DSS-
induced mouse model of acute colitis. Mice were divided
into 4 groups that received different treatments, as illus-
trated in Fig. 6a. Mice administered 2.5% DSS developed
acute colitis characterized by weight loss, bloody diar-
rhoea, and watery stool, and these outcomes were col-
lectively reflected in the increase of the DAI (Disease
Activity Index) score [32] (Fig. 6b). In TB-only group,
the DAI scores remained persistently high even after
DSS administration was discontinued, suggesting that
TB itself did not exert any positive effects toward restor-
ation of a healthy gut condition in mice. It was of par-
ticular interest that E. coli cells expressing tbe2 provided
significant beneficial effects in mice suffering from
Fig. 3 Amino acid sequences and 3-dimensional structures of Tbe1 and Tbe2. a Amino acid sequences and multiple amino acid sequence
alignment of Tbe1, Tbe2, TB esterase of L. lactis (LL_Tbe; UniProtKB Q9L9X0), and esterase of Streptococcus pneumoniae (SP_Est; UniProtKB
A0A0H2UNZ8). Alpha/beta hydrolase conserved domains and significant consensus sequences are highlighted in grey and black, respectively.
Signal peptide is underlined in red. b Partial structure of Tbe1 and Tbe2 modelled by SWISS-MODEL. The models are based on the structure of
the TB esterase of Streptococcus pneumoniae from the RSC Protein Data Bank (2UZ0) as the template. Tbe1, Tbe2, and S. pneumoniae TB esterase
are shown in cyan, pink, and grey, respectively, with the glycerol residue of TB in yellow. Inside the dotted box is the structure containing the
serine-histidine-aspartate (SHD) catalytic triad, as magnified on the right. Each SHD triad of Tbe1, Tbe2 and S. pneumoniae tributyrin esterase are
shown in blue, red, and green, respectively
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severe colitis (Fig. 6b). E. coli cells expressing tbe1 did
not seem to confer any protective effects in comparison
to the empty vector control group (Fig. 6b). It is not
clear why only tbe2-expressing E. coli cells led to the
amelioration of DAI scores.
Another phenotype of the DSS-induced acute colitis is
the shortened intestinal length as gut inflammation
manifests [33]. On day 12, the last day of the experi-
ment, mice from each group were sacrificed and the
lengths of their colons were measured. The colon
lengths of mice that received Tbe1- or Tbe2-expressing
E. coli cells were significantly longer than those of con-
trol mice (Fig. 6c), indicating the positive effects of Tbe
against DSS-induced colitis. Moreover, the intestinal tis-
sues looked significantly improved by Tbe1 or Tbe2.
Hyper-inflammatory responses evidenced by neutrophil
infiltration (black arrow) and fluid accumulation (white
arrows) were observed in DSS-pretreated mice that re-
ceived only TB (Fig. 6d). Still higher degrees of neutro-
phil staining were observed in mice that received control
E. coli cells (Fig. 6e, black arrow). In contrast, intestinal
tissues looked considerably improved when DSS-
pretreated mice were treated with TB and E. coli cells
that express Tbe1 (Fig. 6f) or Tbe2 (Fig. 6g). These re-
sults clearly suggest that on-site butyrate production by
coupling TB and microbiome-derived novel esterases
can exert beneficial effects in the inflamed mouse
intestines.
Discussion
Though computational analysis has enabled significant
progress to be made in recent years, functional metage-
nomic studies using conventional screening methods still
remain irreplaceable and invaluable in the identification
of novel genes and characterization of their functions.
Metagenomic libraries make it feasible to elucidate the
functions of genes from unculturable microbes, which
has remained a major challenge in gut microbiome stud-
ies. For instance, several niche adaptive features of the gut
microbiome such as carbohydrate utilization, colonization
factors, bile acid resistance and antibiotic resistance have
been revealed through the use of metagenomic libraries
constructed from the gut commensal microbiomes of
either human or other mammals [34–37].
Since dietary fibres are a major source for SCFAs in
our gut, many gut metagenome studies have focused on
identifying the genes responsible for the metabolism of
dietary fibres [38]. Due to the differences in microbiome
compositions among individuals, the level of SCFAs pro-
duced from dietary fibres varies significantly [39]. There-
fore, it would be of crucial benefit to strategize an
efficient system of delivering SCFAs in a controlled
manner. Here, we established an on-site butyrate pro-
duction system (OBPS) using a butyrate precursor and
microbiome-derived esterases. We chose TB as a pro-
drug of butyrate and established a functional metagen-
ome screening method that enabled the identification of
genes encoding enzymes that specifically catalyse the
conversion of TB to butyrate.
The success of our screening method is attributed to
the following elements. Firstly, using Triton X-100, we
Fig. 4 Comparison of enzyme activities of Tbe1 and Tbe2 with
LL_Tbe and SP_Est. The tEc cells producing Tbe1 (orange), Tbe2
(green), LL_Tbe (blue) or SP_Est (purple) were examined for the
production of p-nitrophenol, a breakdown product of p-nitrophenol
butyrate (p-NPB). Bacterial cells were incubated with the enzyme
reaction mixture for 5 min and the absorbance at 400 nm was
measured every 10 s. The tEc strain harboring the empty pBAD24
plasmid was used as a negative control (red). Three independent
experiments were conducted, and values of means ± SEM are
displayed in each data point
Fig. 5 Tbe1 and Tbe2 effectively degrade TB and release butyrate.
Measurement of butyrate production by tEc strains harbouring
pBAD24::tbe1 (Tbe1) and pBAD24::tbe2 (Tbe2) are compared to that
of tEc with empty pBAD24 (Control). Bacterial culture was
supplemented with 5 mM TB and incubated for 24 h. Three
independent experiments were performed, and values (means ±
SEM) are displayed in each bar. **, P < 0.05 versus Control
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were able to homogenously solidify agar plates that con-
tain highly insoluble TB. TB agar plates acted as an in-
credibly useful platform, via which high-throughput
screening of a large genomic library was performed with
minimal plate-to-plate variations. Secondly, the character-
istic scent of butyrate aided the differentiation of positive
clones from negative ones, especially during the verifica-
tion stage. Thirdly, TB is a commonly used substrate in
esterase assays, yet previous studies have mostly focused
on the enzymes rather than the products of the enzymatic
reactions. We focused on the fact that TB is an ester of 3
molecules of butyrate condensed with glycerol, and that
positive clones would likely generate butyrate as the major
product of TB degradation. Fourthly, TB, as a food-grade
lipid, can safely be fed to live animals as a prodrug of bu-
tyrate, with no expected side-effects. Thus, TB could be
safely administered to experimental animals and enabled
in vivo confirmation of beneficial effects of TB combined
with esterase containing clones.
Until now, TB esterase has gained attention in the
context of fermented food and agricultural industries
[27, 40, 41]. Here, we report the discovery of novel ester-
ases in the gut, Tbe1 and Tbe2. These esterases were
predicted to have originated from two separate phyla;
Firmicutes and Bacteroidetes, two predominant phyla of
the human intestine [42]. Given that these phyla are
highly abundant and commonly found across individuals
irrespective of geography, race, gender and other charac-
teristics, we speculate that this esterase function serves a
physiologically significant role and is inherent across a
broad spectrum of microbial species in the intestine.
Interestingly, Tbe1 and Tbe2 share a common catalytic
feature. Alpha/beta hydrolase domain is highly con-
served among various hydrolytic enzymes [43]. Serine
residue of the Ser-His-Asp (SHD) catalytic triad, a typ-
ical catalytic motif found in the alpha/beta hydrolase do-
main, is an essential residue for the enzymatic activity of
esterases [30] and often included in the consensus se-
quence (Gly-x-Ser-x-Gly; x refers to any amino acid)
[29]. The amino acid sequences of Tbe1 and Tbe2 both
contain the sequence GLSMGG which is found in other
known TB esterases. The other two residues, histidine
and aspartate, are included in the other two consensus
sequences, LLHG and DFL, respectively.
The DNA fragment insert of 33E2 is highly homologous
to the genome of Lachnospiraceae. Lachnospiraceae is a
gram-positive family that belongs to the Firmicutes
phylum. Genera such as Blautia, Coprococcus, Dorea,
Lachnospira, Oribacterium, and Roseburia are included in
this family. Members of Lachnospiraceae are specialised in
utilising plant derived-polysaccharides such as starch, inu-
lin, and arabinoxylan [44]. Similar to Bacteroides spp.
which have well-established carbohydrate utilization sys-
tems encoded within polysaccharide utilization loci (PUL),
several members of Lachnospiraceae have been reported
to possess similar genomic features termed gram-positive
PUL (gpPUL). gpPUL is defined as a collection of genes
encoding at least one of 3 components: polysaccharide-
degrading enzyme, a carbohydrate transport system and a
transcriptional regulator [44]. Moreover, esterases are fre-
quently present within a gpPUL. Some ORFs of 33E2 cor-
respond with the 3 components of gpPUL; ORF7 and
Fig. 6 Effects of TB and Tbe on dextran sulphate sodium (DSS)-induced colitis. a Schematic diagram of DSS-induced colitis model, b disease
activity index (DAI) score, and c colon length of colitis induced mice treated with only TB (TB ONLY), TB with tEc with empty pBAD24 (TB + Con),
tEc with pBAD24::tbe1 (TB + Tbe1) and tEc with pBAD24::tbe2 (TB + Tbe2). (D-G) Representative images of H&E stained sections of colons from
indicated groups. Arrows denote neutrophil infiltration (black) and edema (white). *, P < 0.05 versus TB + Con
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ORF8 are predicted as ABC transporter permeases, and
ORF9 is a response regulator. Hence, it seems highly pos-
sible that Tbe1 of 33E2 is involved in carbohydrate deg-
radation of Lachnospiraceae. The carbohydrate degrading
ability of Tbe1 may not be limited to TB, but also be ex-
tended to include other various polysaccharides, particu-
larly those that are indigestible by host.
In addition, we examined the effects of TB esterase
and TB oral supplementation on the gut barrier function
in DSS-induced colitis mouse model. TB delivered via
the oral route can be hydrolysed by pancreatic and gas-
tric lipases. Hence, many studies have demonstrated that
solely administered TB mediates an anti-inflammatory
effect. Mounting evidence suggest that supplementation
of TB could induce desirable phenotypes in diet-induced
obesity model [45], in piglets [46, 47], and in a murine
model of Clostridium difficile infection [48]. In this
study, we identified microbiome-derived genes encoding
active TB esterases and sub-cloned them into an E. coli
strain with strong intestinal colonization capability [31].
When those strains were delivered together with TB into
the mouse intestines, on-site production of butyrate was
achieved. More importantly, thus produced butyrate was
sufficient for alleviating the inflammatory symptoms in
the mouse model of acute colitis.
In the present study, we report the finding of two
novel TB esterases, yet our experiments have the follow-
ing limitations: (i) the limited amount of information re-
garding TB esterases present in the gut meant that there
was no suitable esterase to compare TB degrading activ-
ities of the enzymes to; (ii) TB was the only substrate
tested in this study and the substrate specificity of Tbe1
and Tbe2 has not yet been fully explored; (iii) given that
Tbe1 likely originated from gram-positive Lachnospira-
ceae, E. coli might not be an appropriate surrogate host
for Tbe1 expression; (iv) despite strenuous efforts, we
were unable to detect consistently elevated levels of bu-
tyrate in mouse faecal matters discharged from groups
of TB + Tbe1 or TB + Tbe2. We expect that this can be
attributed to the rapid metabolism of butyrate by host
colonocytes. Further investigations of real-time butyrate
production in mouse intestines are required to better ra-
tionalize the therapeutic use of OBPS.
Commercially available probiotics are often limited in
that the delivered bacterial strains have difficulty stably
colonizing the recipient gut and that sufficient amounts
of dietary fibre must be available for bacterial cells to
exert beneficial effects. However, the OBPS is advanta-
geous in that it is simple, yet the level of butyrate pro-
duced can be controlled by the administrator. Therefore,
given the abundant evidence for the significance of bu-
tyrate in the maintenance of a healthy gut [5–7], the
OBPS may prove to be an invaluable treatment option
for various diseases.
Materials and methods
Bacterial strains and culture conditions
The procedure for BAC (Bacterial Artificial Chromo-
some) library construction was described in detail else-
where [23]. Briefly, bacterial DNA was extracted from
the combined caecal and colon contents of seven BALB/
c mice and digested with HindIII restriction enzyme.
The size-selected DNA was cloned into pIndigoBAC-5
(HindIII cloning-ready; Epicentre), and transformed into
E. coli DH10B. Successfully transformed E. coli DH10B
was grown in Luria Broth (LB, 10 g tryptone, 5 g NaCl,
5 g yeast extract per litre) supplemented with 25 μg/ml
of chloramphenicol (Duchefa Biochemie, Haarlem,
Netherlands) at 37 °C. The indigenous non-pathogenic
E. coli strains tEc (typical E. coli) was isolated from CD-1
mouse intestines in a previous study [31]. Lactococcus
lactis (KCTC 3619) was cultured anaerobically in Brain
Heart Infusion (BHI) broth at 37 °C. Streptococcus pneu-
moniae (ATCC 49619) was cultured aerobically in BHI
broth at 37 °C. This information is summarised in
Table 3.
Screening of BAC library clones for TB degrading ability
For TB degradation assay, bacteria were grown on TB
agar (TBA; 4 g peptone, 3 g NaCl, 3 g yeast extract, 15 g
agar, 20 mMTB per litre and 0.02% of triton X-100 as a
surfactant) at 37 °C for 48 h. As TB in the media gets de-
graded by the hydrolytic activity of bacteria, distinct
clear zones form around the bacterial colonies.
Measurement of butyrate
Bacteria were inoculated into 3 ml of TB broth (TBA
without agar) within 50 ml conical tubes and incu-
bated at 37 °C for 24 h. TB concentrations used for
the initial screening of the metagenomic library and
for confirmation of successfully transformed tEc
clones were 20 mM and 5 mM, respectively. Bacterial
culture supernatants were filtered using 0.2 μm Minis-
art® Syringe Filters (Sartorius, Germany). Butyrate
concentration was measured by high-performance li-
quid chromatography (HPLC) using Ultimate3000
(Thermo Dionex, USA) with a UV detector (210 nm)
and refractive index detector (RefractoMAX520,
Japan). For analysis, the Aminex 87H column (300 ×
10 mm, Bio-Rad, CA, USA) was used and 0.01 N
H2SO4 (Fluka, USA) were used as an eluent.
Sequence analysis of the inserted fragments of 33E2 and
54E5
Whole genome sequencing and de novo assembly of
BAC plasmids were performed by Macrogen, Inc. (Seoul,
Korea). ORFs were detected using the ORFfinder pro-
vided by the National Center of Biotechnology Informa-
tion (NCBI). Sequence homology searches were
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performed against the NCBI database using BLASTn
and BLASTp algorithms. ORFs were confirmed with
Prokka [49], and any candidates without significant hits
with BLASTp were excluded from analysis. Conserved
domain search was done by using InterPro database and
signal peptide sequence of protein was predicted based
on SignalP 5.0 [50].
Construction of E. coli heterologously expressing tbe1 and
tbe2
pBAD24 with an ampicillin resistance marker was used
to construct the protein expression vectors (Table 3).
The DNA fragment of tbe1 including the endogenous
promoter region (~ 899 bp) was PCR amplified from the
33E2 clone. The DNA fragment of tbe2 was PCR ampli-
fied from 54E5. Since the endogenous promoter region
of tbe2 was not included in the vector of 54E5, the pro-
moter region of tbe1 was amplified and combined with
the amplified fragment of tbe2 by overlapping PCR (~
1298 bp). PCR products were cloned into the multi-
cloning site of the pBAD24, and the cloned vectors,
named pBAD24::tbe1 and pBAD24::tbe2, were trans-
formed into E. coli DH10B for amplification. Again, the
vectors were extracted from E. coli DH10B using Accu-
Prep Plasmid Mini Extraction kit (Bioneer, Korea) and
transformed into tEc. PCR primers used for cloning are
listed in Table 4.
Esterase enzyme activity assay
Tributyrin esterase activity was assessed following proce-
dures described elsewhere [51], using a chromogenic
substrate, p-nitrophenyl butyrate (p-NPB, Sigma Aldrich,
USA). Production of p-nitrophenol was monitored spec-
trophotometrically by measuring absorbance at 400 nm.
For this assay, tEc transformed with the esterase gene
was cultivated for 6 h in LB broth, and then 20 μl aliquot
was added to the enzyme reaction mixture of final vol-
ume 200 μl.
Dextran sodium sulphate (DSS) mouse model of acute
colitis
Acute colitis was induced in 8-week-old female C57BL/6
mice administered 2.5% dextran sodium sulphate (DSS;
molecular weight, 36,000–50,000 Da; MP Biomedicals,
OH, USA) in their drinking water for 5 days, which was
replaced with normal drinking water for the following 7
days. The mice were monitored daily for body weight,
stool consistency and stool bleeding. Disease activity
index (DAI) scores were taken in accordance with a pre-
vious study [32]. Over the 7-day period following the
DSS administration, mice were orally dosed with TB (3
g/kg) combined with the respective treatments. The
treatments delivered were PBS, tEc-pBAD24 (empty vec-
tor), tEc-pBAD24::tbe1, and tEc-pBAD24::tbe2, respect-
ively. The dosage of each bacterial clones provided in
Table 3 Bacterial strains and plasmids used in this study
Strains and plasmids Relevant characteristic Source
E. coli strains
DH10B pIndigoBAC-5 without inserted gene Laboratory collection
BAC library DH10B, pIndigoBAC-5 harboring BALB/c mouse gut microbiome DNA [23]
tEc wild type strain isolated from CD-1 mouse intestines [31]
tbe1 tEc, pBAD24::tbe1 This study
tbe2 tEc, pBAD24::tbe2 This study
L. lactis Type strain KCTC 3619 Laboratory collection
S. pneumoniae Type strain ATCC 49619 Laboratory collection
Plasmids
pIndigoBAC-5 Cpr, library backbone vector Laboratory collection
pBAD24 Ampr, cloning vector Laboratory collection
Table 4 Primers used in this study







a Restriction enzyme recognition sequences and overlapped sequences are underlined
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combination with TB were 1 × 108 CFU. The mice were
euthanized by CO2 on the 12th day of the experiment
and colon lengths were measured.
Histological analysis
Mouse colons of 3 mm were harvested, opened longitu-
dinall and fixed in 3.7% formaldehyde. Tissues were
paraffin-embedded and 5 μm sections were stained with
haematoxylin-eosin (H&E). Slides were analysed using
an Olympus Microscope (Model. U-LH100HG).
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The online version contains supplementary material available at https://doi.
org/10.1186/s13036-021-00259-4.
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